Antibodies directed against amyloid-beta peptide
US7927594B2 · kind B2 · utility
16Cited by
113References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 1, 2005 |
| Grant date | Apr 19, 2011 |
| Priority date | — |
| Expiry date | Mar 14, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Monoclonal antibody 9TL and antibodies derived from 9TL directed against amyloid-beta peptide and methods of using same for diagnosing and treatment of Alzheimer's disease and Aβ peptide associated diseases are described. Methods of using antibodies directed against amyloid-beta peptide having impaired effector function for treatment of Alzheimer's disease and Aβ peptide associated diseases are also described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.